Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase pseudogenes are genomic DNA sequences with high similarity to the active NADH dehydrogenase genes (such as those encoding subunits of mitochondrial complex I), but they carry mutations, deletions, or insertions that make them non-functional at the protein level[1]. In the human genome, multiple pseudogenes exist related to NADH dehydrogenase subunits; for example, NDUFV2P1 is a pseudogene related to the functional NDUFV2 gene[1]. While pseudogenes do not encode active enzymes or therapeutic targets, some may be transcribed and produce non-coding RNAs with regulatory effects, such as acting as competitors for microRNAs or influencing local chromatin structure, though such roles remain mostly speculative and rare[3]. They are not considered therapeutic targets. The Ensembl ID ENSG00000267713 refers specifically to a pseudogene, not to an active protein-coding gene or classical drug target[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase pseudogene.